What the COVID relief package allocates for vaccines
Mar 10, 2021

What the COVID relief package allocates for vaccines

There's about $14 billion to speed up the distribution and administration of vaccines across the country, and $46 billion to expand COVID testing and to enhance contact tracing capabilities. Plus, the Nasdaq's correction this week and wider trends about where investors are putting their money and why.

Segments From this episode

"The definition of volatility in the market"

By the end of Monday, the tech-heavy Nasdaq fell 2.4%, putting it in correction territory, down 10% from a recent high. Then, Tuesday comes around, and the Nasdaq posts its biggest rise in four months, up 3.7%. Susan Schmidt, head of U.S. equities at Aviva Investors, says that in some ways this movement is “very understandable.” “Remember that that Nasdaq index has been our outperformer of the indices, not only last year but the last two years. Last year that index was up over 40%.” Schmidt says investors are torn whether to continue putting money into tech stocks, which have done so well over the course of the pandemic, or if they want to diversify over other industries, too, with stimulus on the way and other businesses slated to benefit over the course of a recovery.

Music from the episode

Palm Trees Loop Schrauber

The team

Victoria Craig Host, BBC
Stephen Ryan Senior Producer, BBC
Jonathan Frewin Producer, BBC
Daniel Shin Producer
Jay Siebold Technical Director
Brian Allison Engineer
Meredith Garretson Morbey Senior Producer
Erika Soderstrom Producer
Rose Conlon Producer
Alex Schroeder Producer